Literature DB >> 21802870

Turner syndrome and metabolic derangements: another example of fetal programming.

Alexandre Duarte Baldin1, Adriana Aparecida Siviero-Miachon, Tatiana Fabbri, Sofia Helena Valente de Lemos-Marini, Angela Maria Spinola-Castro, Maria Tereza Matias Baptista, Lilia Freire Rodrigues D'Souza-Li, André Moreno Morcillo, Andrea Trevas Maciel-Guerra, Gil Guerra-Junior.   

Abstract

BACKGROUND AND AIM: Turner syndrome (TS) patients have an increased risk of weight gain and metabolic syndrome. To date, it is unknown what factors are involved in this metabolic process, even though it is recognized that TS patients are frequently born small-for-gestational age. The aim of this study was to evaluate the correlation between lipid and glucose profiles with being overweight and birth weight and length in TS patients. STUDY
DESIGN: This was a cross-sectional study. SUBJECTS AND OUTCOME MEASURES: Serum glucose, insulin (HOMA-IR), total cholesterol, and triglycerides were measured in 64 patients with TS. Data regarding birth weight and length and current body mass index (BMI) were also evaluated.
RESULTS: Total cholesterol showed a significant negative correlation with birth weight and a positive correlation with BMI; triglycerides showed significant negative correlation with birth weight and length and a positive correlation with BMI; and HOMA-IR showed a significant negative correlation with birth weight and length. Low birth weight and a high BMI were predictive for 28% of total cholesterol and triglycerides; and low birth weight for 22% of HOMA-IR.
CONCLUSIONS: Lipid profile was correlated with a high current BMI and low birth weight and length in TS patients and glucose profile only with low birth weight. Thus far, growth retardation may play a role in metabolic derangements in this group of patients, being considered another example of fetal programming. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21802870     DOI: 10.1016/j.earlhumdev.2011.07.014

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  6 in total

Review 1.  Developmental origins of metabolic diseases.

Authors:  Daniel J Hoffman; Theresa L Powell; Emily S Barrett; Daniel B Hardy
Journal:  Physiol Rev       Date:  2020-12-03       Impact factor: 46.500

Review 2.  Sex differences in obesity, lipid metabolism, and inflammation-A role for the sex chromosomes?

Authors:  Temeka Zore; Maria Palafox; Karen Reue
Journal:  Mol Metab       Date:  2018-04-12       Impact factor: 7.422

3.  Metabolic Syndrome as a Risk Factor for Sensorineural Hearing Loss in Adult Patients with Turner Syndrome.

Authors:  Francisco Álvarez-Nava; Marcia Racines-Orbe; Julia Witt; Jéssica Guarderas; Yosselin Vicuña; María Estévez; Roberto Lanes
Journal:  Appl Clin Genet       Date:  2020-01-13

Review 4.  Sex hormones, intestinal inflammation, and the gut microbiome: Major influencers of the sexual dimorphisms in obesity.

Authors:  Holly Brettle; Vivian Tran; Grant R Drummond; Ashley E Franks; Steve Petrovski; Antony Vinh; Maria Jelinic
Journal:  Front Immunol       Date:  2022-09-27       Impact factor: 8.786

Review 5.  Cardiometabolic and vascular risks in young and adolescent girls with Turner syndrome.

Authors:  Meenal Mavinkurve; Clodagh S O'Gorman
Journal:  BBA Clin       Date:  2015-04-30

Review 6.  Epigenetics in Turner syndrome.

Authors:  Francisco Álvarez-Nava; Roberto Lanes
Journal:  Clin Epigenetics       Date:  2018-04-06       Impact factor: 6.551

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.